NCT03230227View on ClinicalTrials.gov

Presternal Magnesium With Bupivacain Versus Bupivacain Only for Postoperative Pain Relief in Open Heart Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacaine magnesium

bupivacain 0.125% magnesium sulfate 5%) infusion in the presternum , for 48 hours

DRUG

Bupivacaine only

bupivacaine 0.125% infusion in the presternum , for 48 hours

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03230227 - Presternal Magnesium With Bupivacain Versus Bupivacain Only for Postoperative Pain Relief in Open Heart Surgery | Biotech Hunter | Biotech Hunter